skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Good Morning

According to my broker's website IPL insiders performed the following transactions on December 31, 2018:

NATURE OF TRANSACTION SECURITY PRICE
Rights Exercise Rights Restricted Share Units $19.18

Over 140,000 share units were involved

Can you please explain as to what these transactions are all about ? Are they rights not exercised? Further are these transactions positive with respect to the activities of the insiders?

In general what is your opinion with respect to the activities of the IPL insiders?
Thank you as always for your insight.

Read Answer Asked by Terry on February 20, 2019
Q: Hi guys
I have held Lassonde for a long time and done very well, but the past year has not been kind to the stock price. And then there is this recent profit warning. I have not issue being patient if this is a blip but wonder whether this is the start of a trend with trade issues and people turning away from fruit juices. Your thoughts on this profit warning and this company going forward. By the way thank you so very much for bringing CSU to my attention as it has gone up exponentially since your recommendation many years ago. I harvested a bit of my profits today to bring the holding back to 5%.
Thanks
Stuart
Read Answer Asked by Stuart on February 20, 2019
Q: Hi team,

This is my first non-tech question in quite a while. I try to balance my tech stocks with some names in other sectors. CF came to my attention today from a TD report. It is on one of my watch lists but I haven’t followed it closely in a couple of years. TD gives it a Buy, Higher Risk rating with a target of $9.50 although I don’t find target prices very meaningful. Part of their rationale is CF’s recent purchase of U.S.-based advisory firm Petsky Prunier, who focus on mid-market segments and have a growing presence in the cannabis space for IPOs and mergers in the U.S. CF itself seems to have a strong presence in cannabis deals in Canada and potentially internationally. The cannabis segment is here to stay, regardless of the high valuations. I am not a weed guy as such, but if CF can continue to grab a good chuck of these deals, it may bode well for it.

What are the pros and cons of an investment in CF at this time? I notice you gave it a B- in your Company report last August, which is not a strong grade, but perhaps things have changed.

Thanks again.
Dave
Read Answer Asked by Dave on February 20, 2019
Q: Hi team,

What are your thoughts of initiating a position in BRK-B at current levels for a long term hold?

Thanks
Read Answer Asked by Keith on February 20, 2019